-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Tuberous Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Tuberous Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Tuberous Sclerosis Drug Details: LP-352 (AN-352) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VB-119 in Kidney Disease (Nephropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VB-119 in Kidney Disease (Nephropathy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VB-119 in Kidney Disease (Nephropathy) Drug Details: VB-119 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Narmafotinib in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Narmafotinib in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Narmafotinib in Pancreatic Cancer Drug Details: AMP-945 (CTX-0294945) is under investigation for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Lennox-Gastaut Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Lennox-Gastaut Syndrome report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Lennox-Gastaut Syndrome Drug Details: LP-352 (AN-352) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexicaserin in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexicaserin in Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexicaserin in Dravet Syndrome (Severe Myoclonic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – XEN-1101 in Tonic-Clonic (Grand Mal) Seizure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XEN-1101 in Tonic-Clonic (Grand Mal) Seizure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XEN-1101 in Tonic-Clonic (Grand Mal) Seizure Drug Details: XEN-1101 (1OP-2198)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Darigabat in Seizures
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Darigabat in Seizures report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Darigabat in Seizures Drug Details: Darigabat (CVL-865) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sofpironium Bromide in Axillary Hyperhidrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sofpironium Bromide in Axillary Hyperhidrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sofpironium Bromide in Axillary Hyperhidrosis Drug Details: Sofpironium bromide (Ecclock)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Darigabat in Panic Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Darigabat in Panic Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Darigabat in Panic Disorders Drug Details: Darigabat (CVL-865) is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Abiprubart in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abiprubart in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abiprubart in Rheumatoid Arthritis Drug Details: Abiprubart is under development for the...